Pharyngitis Therapeutics Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
REPORT DESCRIPTION<br />
<strong>Pharyngitis</strong> <strong>Therapeutics</strong> <strong>Market</strong> : Overview<br />
<strong>Pharyngitis</strong>, commonly referred to as sore throat, causes inflammation of pharynx<br />
located behind the throat. <strong>Pharyngitis</strong> is caused by bacterial or viral infections and<br />
cases of pharyngitis are majorly observed in colder months of the year. Measles,<br />
adenovirus, chickenpox, croup, whooping cough, and group A streptococcus are the<br />
major causes of pharyngitis. <strong>Pharyngitis</strong> is also commonly caused by viral<br />
infections such as common cold, influenza, and mononucleosis. According to the<br />
Centers for Disease Control and Prevention (CDC), amoxicillin and penicillin are<br />
the most commonly prescribed treatments for sore throat.<br />
<strong>Pharyngitis</strong> treatment is majorly based on the symptoms, depending the cause of<br />
pharyngitis for example, bacterial, fungal, and herpes simplex infections. The<br />
common symptoms of pharyngitis include sneezing, runny nose, headache, cough,<br />
fatigue, body aches, chills, and fever. Additionally, strep throat condition also<br />
occurs, which may lead to difficulty in swallowing, loss of appetite, nausea, fever,<br />
loss of taste, and swollen lymph nodes.<br />
© Coherent market Insights. All Rights Reserved
Change language